Mol. Angiotensin II type 1 receptor (AT1R) is a promising therapeutic target for cardiovascular diseases. Integrated computational approaches and tools for allosteric drug discovery. . Roustem has several funds of hedge funds under management. Roustem Gareyev David has several funds of hedge funds under management. Özbilgin & Sibel Yamak. Sheik. Bertrand is a